Moleculin Biotech Stock Forecast - Rate Of Daily Change
| MBRX Stock | USD 4.35 0.25 5.43% |
Moleculin Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Moleculin Biotech stock prices and determine the direction of Moleculin Biotech's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Moleculin Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Moleculin Biotech's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Moleculin Biotech's systematic risk associated with finding meaningful patterns of Moleculin Biotech fundamentals over time.
Check out Historical Fundamental Analysis of Moleculin Biotech to cross-verify your projections. Moleculin |
Most investors in Moleculin Biotech cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Moleculin Biotech's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Moleculin Biotech's price structures and extracts relationships that further increase the generated results' accuracy.
Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Moleculin Biotech.| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 1.07 | 0.95 |
| Check Moleculin Biotech Volatility | Backtest Moleculin Biotech | Information Ratio |
Moleculin Biotech Trading Date Momentum
| On April 24 2024 Moleculin Biotech was traded for 4.35 at the closing time. The top price for the day was 4.62 and the lowest listed price was 4.35 . The trading volume for the day was 7.4 K. The trading history from April 24, 2024 did not cause price change. The trading delta at closing time against the current closing price is 5.75% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare Moleculin Biotech to competition |
Other Forecasting Options for Moleculin Biotech
For every potential investor in Moleculin, whether a beginner or expert, Moleculin Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Moleculin Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Moleculin. Basic forecasting techniques help filter out the noise by identifying Moleculin Biotech's price trends.View Moleculin Biotech Related Equities
| Risk & Return | Correlation |
Moleculin Biotech Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Moleculin Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Moleculin Biotech's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Moleculin Biotech Market Strength Events
Market strength indicators help investors to evaluate how Moleculin Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moleculin Biotech shares will generate the highest return on investment. By undertsting and applying Moleculin Biotech stock market strength indicators, traders can identify Moleculin Biotech entry and exit signals to maximize returns.
Moleculin Biotech Risk Indicators
The analysis of Moleculin Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Moleculin Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting moleculin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.5 | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Moleculin Biotech to cross-verify your projections. For more information on how to buy Moleculin Stock please use our How to Invest in Moleculin Biotech guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Moleculin Stock analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Moleculin Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moleculin Biotech. If investors know Moleculin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moleculin Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.15) | Return On Assets (0.39) | Return On Equity (0.76) |
The market value of Moleculin Biotech is measured differently than its book value, which is the value of Moleculin that is recorded on the company's balance sheet. Investors also form their own opinion of Moleculin Biotech's value that differs from its market value or its book value, called intrinsic value, which is Moleculin Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moleculin Biotech's market value can be influenced by many factors that don't directly affect Moleculin Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moleculin Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moleculin Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moleculin Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.